August 2009- Volume 5, Issue 8

August 2009

In this Issue

News Briefs

House vote a victory for biotechs in biosimilars battle

House vote a victory for biotechs in biosimilars battle

A House panel has approved a provision in legislation that would give biosimilar drugs 12 years of protection from competing medicines.

Genomics & Proteomics

Sticking its feet into the pool

Sticking its feet into the pool

Alnylam joins GSK in donating intellectual property to patent pool for neglected tropical diseases

Protein power

Protein power

Celera issues licenses for five oncology targets to Bayer Schering Pharma

Two Xs mark diagnostic spot

Two Xs mark diagnostic spot

Exosome Diagnostics and DxS collaborate to develop blood-based tests for key cancer mutations

High-value vaccine investment

High-value vaccine investment

Juvaris to use Antigen Discovery’s protein microarray screening system to discover disease-specific antigens and fuel its vaccine pipeline

De novo gene genesis

De novo gene genesis

Researchers identify primate-specific sequences in the human genome in comparative genomics study

Research & Development

They’re bonded by blood

They’re bonded by blood

Catalyst Biosciences, Wyeth Pharmaceuticals team up to treat hemophilia in collaboration worth up to $500 million

Antibody partnership has eggs-cellent potential

Antibody partnership has eggs-cellent potential

Morphotek partners with Synageva BioPharma to develop therapeutic monoclonal antibodies

Protein partners from opposite sides of the Pacific

Protein partners from opposite sides of the Pacific

California-based Maxygen and Japan-based Astellas form joint venture around protein therapies

A merger of equals in specialty diagnostics

A merger of equals in specialty diagnostics

Viracor merges molecular diagnostic testing services with IBT Laboratories’ focus on immunology testing to create specialty diagnostics company

J&J's spending spree continues

J&J's spending spree continues

Johnson & Johnson buys $1 billion stake in Elan to acquire Alzheimer's program

Global News

Geron to provide stem cells to GE Healthcare

Geron to provide stem cells to GE Healthcare

Companies to develop and commercialize cellular assay products derived from human embryonic stem cells

Let it bleed

Let it bleed

CDI reprograms blood cells into stem cells using a small volume of human blood; expands drug testing agreement with Roche

Failed drugs reincarnated

Failed drugs reincarnated

Israel’s Optimata, Teva join forces to develop salvaged cancer drugs

Bolus of growth

Bolus of growth

Mylan chooses Bangalore’s Biocon as global generic biologics partner

A flurry of activity

A flurry of activity

Shifting its focus to neurological conditions, Lundbeck acquires Danish biotech NeuronIcon and U.K.-based drugmaker LifeHealth

Survive to thrive

Survive to thrive

CombinatoRx, Neuromed to merge in all-stock transaction

Automation & Instrumentation

Blood test for Alzheimer's disease likely within 12 to 18 months

Blood test for Alzheimer's disease likely within 12 to 18 months

Millipore and Proteome Sciences sign licensing agreement to detect the disease in pre-symptomatic stage

An array of advantages

An array of advantages

Aushon’s 2470 microarray printer to provide customized solution for small-molecule screening at the Broad Institute.

Nanos from the bottom up

Nanos from the bottom up

Particle Sciences and Microfluidics combine to advance pharmaceutical nanotechnology

Analytical team-up

Analytical team-up

RTS Life Science is partnering with Hall Analytical Laboratories to provide analytical services and consultancy in automation, inhaler testing

Aiming to create the ‘disposable factory’

Aiming to create the ‘disposable factory’

Sartorius Stedim Biotech partners with SAFC Biosciences to integrate filtration and liquid handling systems with cell culture media manufacturing services.

Informatics

Swiss success

Swiss success

Medidata makes important deals with two different Swiss pharma companies in a two-week period

Search for pathway-level biomarkers

Search for pathway-level biomarkers

Agilent Foundation awards grant to UCSD to develop system for analyzing proteomics data and identifying protein-network cancer biomarkers

A new home for SQL*LIMS

A new home for SQL*LIMS

Seeking new strategic direction, Life Technologies sells laboratory information management software business to LabVantage

TGen tapped for ‘biobank’

TGen tapped for ‘biobank’

Luxembourg selects TGen to create biobank for storage of blood and tissue samples for scientists

A ‘crossomics’ collaboration

A ‘crossomics’ collaboration

Genedata AG signs multi-year bioinformatics deal with Roche subsidiary Chugai Pharmaceuticals

Editor's Focus

Foreign governments feed biotechnology venture capital firms as U.S. appetite for bailouts wanes

Foreign governments feed biotechnology venture capital firms as U.S. appetite for bailouts wanes

While the suggestion that the United States government bail out venture capital firms has failed to attract support from government leaders—and would surely raise taxpayer ire—the mood is quite different overseas, according to recent media reports.

Patent News

Senate Committee: 12 years of data exclusivity is cool

Senate Committee: 12 years of data exclusivity is cool

The U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee voted last month in favor of a proposal by Sens. Kay Hagan (D-N.C.), Michael Enzi (R-WY) and Orrin Hatch (R-UT) to create a follow-on biologics (FOB) pathway that provides 12 years of data exclusivity for brand-name biologic drugs.

Commentary

Guest commentary: American pathway to generic biologics approval remains undefined

Guest commentary: American pathway to generic biologics approval remains undefined

As we stand at the forefront of major changes across the healthcare industry, a pathway for the approval of generic biologics will be one of the major initiatives in the government’s efforts to achieve reduced costs.
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

November 2022 Issue Front Cover

Latest Issue  

• Volume 18 • Issue 11 • November 2022

November 2022

November 2022